L1CAM and neoplasm: However, while L1CAM-positive tumors clearly have worse outcomes, it is prudent to maintain the original TCGA tumor subgroups and to not consider L1CAM tumors a subtype but rather as a prognostic subgroup of the large p53 wild-type group with no specific molecular risk profile (NSMP) and perhaps of MMR-D tumors [44].